Intravesical drug delivery devices

US12296127B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12296127-B2
Application numberUS-202318125810-A
CountryUS
Kind codeB2
Filing dateMar 24, 2023
Priority dateDec 11, 2007
Publication dateMay 13, 2025
Grant dateMay 13, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An implantable medical device is provided for controlled drug delivery within the bladder, or other body vesicle. The device may include at least one drug reservoir component comprising a drug; and a vesicle retention frame which comprises an elastic wire having a first end, an opposing second end, and an intermediate region therebetween, wherein the drug reservoir component is attached to the intermediate region of the vesicle retention frame. The retention frame prevents accidental voiding of the device from the bladder, and it preferably has a spring constant selected for the device to effectively stay in the bladder during urination while minimizing the irritation of the bladder.

First claim

Opening claim text (preview).

We claim: 1. An intravesical drug delivery device comprising: a tubular body housing a drug, wherein the tubular body is formed in a configuration having a sufficient spring constant to retain the device in a patient's bladder, and wherein the tubular body has a shape which has exactly two smaller arches sharing a single common larger arch. 2. The device of claim 1 , wherein the spring constant is from 3 N/m to 60 N/m. 3. The device of claim 1 , wherein the spring constant is from 3.6 N/m to 3.8 N/m. 4. The device of claim 1 , wherein the tubular body comprises silicone. 5. The device of claim 1 , wherein the drug is part of a solid drug formulation. 6. The device of claim 1 , wherein the tubular body comprises an aperture configured to release the drug therethrough. 7. The device of claim 1 , wherein the tubular body has no aperture and is configured to release the drug by diffusion through a wall in the tubular body. 8. The device of claim 1 , wherein ends of the tubular body are sealed to prevent escape of the drug from the ends. 9. The device of claim 1 , wherein the tubular body comprises a non-resorbable, water permeable material. 10. The device of claim 1 , wherein the tubular body comprises a polyurethane. 11. The device of claim 1 , wherein the drug comprises an antiproliferative agent, a cytotoxic agent, or a chemotherapeutic agent. 12. An intravesical drug delivery device comprising: a drug reservoir portion which contains a drug and controls in vivo release of the drug into a patient's bladder; and a retention frame portion configured to impede voiding of the intravesical drug delivery device from the patient's bladder, wherein the drug reservoir portion and the retention frame portion are the same component of the intravesical drug delivery device, wherein the same component comprises a tubular body having a shape which has exactly two smaller arches sharing a single common larger arch. 13. The device of claim 12 , wherein the tubular body is formed in a configuration having a spring constant from 3 N/m to 60 N/m. 14. The device of claim 12 , wherein the tubular body is formed in a configuration having a spring constant from 3.6 N/m to 3.8 N/m. 15. The device of claim 12 , wherein the tubular body comprises an aperture configured to release the drug therethrough. 16. The device of claim 12 , wherein the tubular body has no aperture and is configured to release the drug by diffusion through a wall in the tubular body. 17. The device of claim 12 , wherein the drug is part of a solid drug formulation. 18. The device of claim 12 , wherein ends of the tubular body are sealed to prevent escape of the drug from the ends. 19. The device of claim 12 , wherein the tubular body comprises a non-resorbable, water permeable material. 20. The device of claim 12 , wherein the tubular body comprises a polyurethane. 21. The device of claim 12 , wherein the drug comprises an antiproliferative agent, a cytotoxic agent, or a chemotherapeutic agent.

Assignees

Inventors

Classifications

  • Bladder · CPC title

  • Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking · CPC title

  • using radio-opaque or ultrasound markers · CPC title

  • Insertion or introduction using an inner stiffening member, e.g. stylet or push-rod · CPC title

  • having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12296127B2 cover?
An implantable medical device is provided for controlled drug delivery within the bladder, or other body vesicle. The device may include at least one drug reservoir component comprising a drug; and a vesicle retention frame which comprises an elastic wire having a first end, an opposing second end, and an intermediate region therebetween, wherein the drug reservoir component is attached to the …
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification A61K9/0024. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).